Yun Fu

1.3k total citations
57 papers, 989 citations indexed

About

Yun Fu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yun Fu has authored 57 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yun Fu's work include Metal complexes synthesis and properties (7 papers), RNA modifications and cancer (6 papers) and RNA Interference and Gene Delivery (5 papers). Yun Fu is often cited by papers focused on Metal complexes synthesis and properties (7 papers), RNA modifications and cancer (6 papers) and RNA Interference and Gene Delivery (5 papers). Yun Fu collaborates with scholars based in China, Mexico and United States. Yun Fu's co-authors include Changzheng Li, Tengfei Huang, Youxun Liu, Sufeng Zhou, Baoan Song, Xiuhai Gan, Yongli Li, Deyu Hu, Xiao‐Qi Yu and Dan Liu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Yun Fu

55 papers receiving 977 citations

Peers

Countries citing papers authored by Yun Fu

Since Specialization

Citations

This map shows the geographic impact of Yun Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Fu more than expected).

Fields of papers citing papers by Yun Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Fu. The network helps show where Yun Fu may publish in the future.

Co-authorship network of co-authors of Yun Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Fu. A scholar is included among the top collaborators of Yun Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Fu. Yun Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-Cell Array Enhanced Cell Damage Recognition Using Artificial Intelligence for Anticancer Drug Discovery 2025 ·Analytical Chemistry ·Qingxuan Li, Junjie Zhou, Songyao Jiang, Yun Fu, Ming Su	4
2	NCOA4-mediated ferroptosis conducive to EMT inhibition in colorectal cancer cells was achieved through the PI3K/AKT/mTOR pathway 2025 ·Scientific Reports ·Yun Fu, Qiufeng Zhao, Yongli Li, Yanjie Sun, (unknown), Cuiping Li, Wei Zhang, Yanyan Yin, (unknown)	0
3	Ferritinophagy-mediated apoptosis and paraptosis induction involved MAPK and PI3K/AKT pathway in mechanism of an iron chelator 2023 ·Biochemical Pharmacology ·Rufang Wang, (unknown), Yun Fu, Yongli Li, Yu Qi, Cuiping Li, (unknown), (unknown), (unknown), (unknown)	7
4	Ferritinophagy‐Mediated ROS Production Contributed to Proliferation Inhibition, Apoptosis, and Ferroptosis Induction in Action of Mechanism of 2‐Pyridylhydrazone Dithiocarbamate Acetate 2021 ·Oxidative Medicine and Cellular Longevity ·Longlong Li, Hao Li, Yongli Li, (unknown), (unknown), Yalei Zhang, Yun Fu, (unknown), Changzheng Li	12
5	Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway 2021 ·Journal of Experimental & Clinical Cancer Research ·Jian Li, (unknown), Peng Shen, (unknown), Peirong Zhou, Guifang Zhu, Yangwei Xu, Yun Fu, (unknown), Jingbo Sun, Jia Xu, Qingling Zhang	0
6	Resveratrol induces human colorectal cancer cell apoptosis by activating the mitochondrial pathway via increasing reactive oxygen species 2020 ·Molecular Medicine Reports ·Yun Fu, (unknown), Guifang Zhu, Yangwei Xu, Jingbo Sun, Hongmei Wu, (unknown), Zhihui Wen, Shanshan Jiang, Yanyan Li, Qingling Zhang	33
7	Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway 2020 ·Journal of Experimental & Clinical Cancer Research ·Jian Li, (unknown), Peng Shen, (unknown), Peirong Zhou, Guifang Zhu, Yangwei Xu, Yun Fu, (unknown), Jingbo Sun, Jia Xu, Qingling Zhang	43
8	Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway 2019 ·PLoS ONE ·Yongli Li, Tengfei Huang, Yun Fu, (unknown), Tiesuo Zhao, Sheng Guo, Yanjie Sun, Yun Yang, Changzheng Li	17
9	A Simple Imaging Device for Fluorescence-Relevant Applications 2018 ·Micromachines ·(unknown), (unknown), (unknown), Yun Fu, J. Andrew Yeh, Da‐Jeng Yao, Chao‐Min Cheng	4
10	The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling 2018 ·Scientific Reports ·Yun Yang, Youxun Liu, Rui Guo, Yun Fu, Ziheng Zhang, Pengfei Zhang, Ping‐Xin Zhou, Tingting Wang, Tengfei Huang, Xiaotong Li, Changzheng Li	14
11	Growth Inhibition of a Novel Iron Chelator, DpdtC, against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy‐Mediated Lysosomal ROS Generation 2018 ·Oxidative Medicine and Cellular Longevity ·Tengfei Huang, Yanjie Sun, Yongli Li, (unknown), Yun Fu, Cuiping Li, Changzheng Li	30
12	Syntheses, antiviral activities and induced resistance mechanisms of novel quinazoline derivatives containing a dithioacetal moiety 2018 ·Bioorganic Chemistry ·Dandan Xie, Jing Shi, Awei Zhang, Zhiwei Lei, (unknown), Yun Fu, Xiuhai Gan, (unknown), Baoan Song, Deyu Hu	45
13	The antiproliferative activity of di-2-pyridylketone dithiocarbamate is partly attributed to catalase inhibition: detailing the interaction by spectroscopic methods 2017 ·Molecular BioSystems ·Cuiping Li, Youxun Liu, Yun Fu, Tengfei Huang, (unknown), (unknown), (unknown)	9
14	Serum miR-20a is a promising biomarker for gastric cancer 2017 ·Biomedical Reports ·Ruirui Yang, Yun Fu, Ying Zeng, (unknown), Yufang Yin, Li Li, Haifan Xu, Jing Zhong, Xi Zeng	44
15	The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent 2017 ·PLoS ONE ·Shun� Lei, Yao Ding, Yun Fu, Shuang Wu, Xiong Xie, Cancan Wang, Houjie Liang	10
16	Antiproliferative activity of di-2-pyridylhydrazone dithiocarbamate acetate partly involved in p53 mediated apoptosis and autophagy 2017 ·International Journal of Oncology ·(unknown), Youxun Liu, Yun Fu, Tengfei Huang, Yun Yang, (unknown), Changzheng Li	12
17	Redox cycling of a copper complex with benzaldehyde nitrogen mustard-2-pyridine carboxylic acid hydrazone contributes to its enhanced antitumor activity, but no change in the mechanism of action occurs after chelation 2015 ·Oncology Reports ·Yinli Yang, Cuiping Li, Yun Fu, Youxun Liu, Yu Zhang, Yanfang Zhang, Ping‐Xin Zhou, (unknown), Sufeng Zhou, (unknown), Changzheng Li	15
18	Antitumor activity of a 2-pyridinecarboxaldehyde 2-pyridinecarboxylic acid hydrazone copper complex and the related mechanism 2015 ·Oncology Reports ·(unknown), Tengfei Huang, Sufeng Zhou, Yun Fu, Youxun Liu, (unknown), (unknown), (unknown), Changzheng Li	10
19	The antitumor mechanism of di-2-pyridylketone 2-pyridine carboxylic acid hydrazone and its copper complex in ROS generation and topoisomerase inhibition, and hydrazone involvement in oxygen-catalytic iron mobilization 2015 ·International Journal of Oncology ·Tengfei Huang, Cuiping Li, (unknown), (unknown), Yun Fu, Youxun Liu, (unknown), (unknown), Changzheng Li	14
20	Cationic Lipids Containing Cyclen and Ammonium Moieties as Gene Delivery Vectors 2012 ·Chemical Biology & Drug Design ·(unknown), Jiang Ren, (unknown), Yun Fu, (unknown), Ji Zhang, Wen Zhu, Xiao‐Qi Yu	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact